Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm|Neoplasm Metastasis
Interventions: DRUG: Monoclonal Antibody 3A1|DRUG: Monoclonal Antibody 95-5-49|DRUG: Monoclonal Antibody 95-6-22|DEVICE: Baxter Isolex 3001 Stem Cell Selection System|DEVICE: Ceprate SC
Sponsor: National Cancer Institute (NCI)